Why the study?
The impact of PMVr on long-term prognosis in FMR remains unclear, and this study aimed to assess the possible influence of classifying FMR as proportionate versus disproportionate based on the EROA/LVEDV ratio on PMVr efficacy.
Does proportionate versus disproportionate functional mitral regurgitation status (based on the EROA/LVEDV ratio) predict cardiovascular death and heart failure rehospitalization at 12 months in patients undergoing percutaneous mitral valve repair with MitraClip?
Cohort (n=56)
No
Does proportionate versus disproportionate functional mitral regurgitation status (based on the EROA/LVEDV ratio) predict cardiovascular death and heart failure rehospitalization at 12 months in patients undergoing percutaneous mitral valve repair with MitraClip?
Answers are grounded in this paper and cite their sources.
Classifying functional mitral regurgitation using the 3D echocardiographic EROA/LVEDV ratio identifies proportionate MR patients who have significantly higher rates of MR recurrence, HF rehospitalization, and CV death after MitraClip repair compared to disproportionate MR patients.
Background: The impact of percutaneous mitral valve repair (PMVr) on long-term prognosis in patients with functional mitral regurgitation (FMR) is still unclear. Recently, a new conceptual framework classifying FMR as proportionate (P-MR) and disproportionate (D-MR) was proposed, according to the effective regurgitant orifice area/left ventricular end-diastolic volume (EROA/LVEDV) ratio. The aim was to assess its possible influence on PMVr efficacy. Methods: A total of 56 patients were enrolled. MV annulus, LV volumes and function were assessed. Global longitudinal strain (GLS) was also calculated. Patients were divided into two groups, according to the EROA/LVEDV ratio. Echocardiographic follow-up was performed after 6 months, and adverse events were collected after 12 months. Results: D-MR patients (n = 28, 50%) had a significantly more elliptical MV annulus (p = 0.048), lower tenting volume (p = 0.01), higher LV ejection fraction (LVEF: 32 ± 7 vs. 26 ± 5%, p = 0.003), lower LVEDV, LV end-systolic volume (LVESV) and mass (LVEDV/i: 80 ± 20 vs. 126 ± 27 mL, p = 0.001; LVESV/i: 60 ± 20 vs. 94 ± 23 mL, p < 0.001; LV mass: 249 ± 63 vs. 301 ± 69 gr, p = 0.035). GLS was more impaired in P-MR (p = 0.048). After 6 months, P-MR patients showed a higher rate of MR recurrence. After 12 months, the rate of CV death and rehospitalization due to HF was significantly higher in P-MR patients (46% vs. 7%, p < 0.001). P-MR status was strongly associated with CV death/rehospitalization (HR = 3.4, CI 95% = 1.3–8.6, p = 0.009). Conclusions: Patients with P-MR seem to have worse outcomes after PVMr than D-MR patients. Our study confirms the importance of the EROA/LVEDV ratio in defining different subsets of FMR based on the anatomical characteristic of MV and LV.
No takes yet. Share an insight, caveat, or question.
Cimino et al. (2022) conducted a cohort in Severe functional mitral regurgitation (FMR) with reduced left ventricular ejection fraction (n=56). Proportionate functional mitral regurgitation (EROA/LVEDV ratio <= 0.14) vs. Disproportionate functional mitral regurgitation (EROA/LVEDV ratio > 0.14) was evaluated on Cardiovascular death and rehospitalization due to heart failure at 12 months (HR 3.4, 95% CI 1.3-8.6, p=0.009).
Synapse has enriched 10 related papers. Consider them for comparative context: